| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |